Drug intelligence / Profile preview

3-(1h-indol-3-yl)-2-[4-(4-phenyl-piperidin-1-yl)-benzenesulfonylamino]-propionic acid

Development stage: Unknown
Modality: Small Molecules

Overview

This compound is a synthetic small molecule with the molecular formula C28H29N3O4S and a molecular weight of approximately 503.6 g/mol[1][2][9]. It contains an indole moiety, a phenylpiperidine group, and a benzenesulfonamide linkage. The compound is listed in chemical databases such as PubChem (CID: 444789) and DrugBank (DB02449), where it is classified as an experimental pharmaceutical agent[1][2]. There are no approved medical indications or clinical trial data available for this molecule, and its mechanism of action has not been characterized in the literature or major drug databases[2][4]. It appears to be primarily of interest for research purposes.

Other names: (2S)-3-(1H-indol-3-yl)-2-[4-(4-phenylpiperidin-1-yl)benzenesulfonamido]propanoic acid

Beyond the preview

Go deeper on 3-(1h-indol-3-yl)-2-[4-(4-phenyl-piperidin-1-yl)-benzenesulfonylamino]-propionic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3-(1h-indol-3-yl)-2-[4-(4-phenyl-piperidin-1-yl)-benzenesulfonylamino]-propionic acid.

Explore the full profile